Fredrick Munzer
Geriatric Medicine · Johnstown, PANPI 1063497584
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.7% of the total across 150 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 20 manufacturers reported payments, led by AstraZeneca at 25.9% of the total. Reporting peaked in 2021 at $781 and has fallen 93.1% since, to $54 in 2023.
Across 150 payments — averaging $15.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$610
- Novo Nordisk$337
- E.r. Squibb & Sons, L.L.C.$224
- AbbVie$207
- Pfizer$183
- Lilly USA, LLC$137
- plus $656 from 14 others
What the payments were for
- Food & beverage$2,348100%
- Education$60%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 30 | $610 |
| Novo Nordisk | 34 | $337 |
| E.r. Squibb & Sons, L.L.C. | 15 | $224 |
| AbbVie(2 entities) | 7 | $207 |
| Pfizer | 17 | $183 |
| Lilly USA, LLC | 10 | $137 |
| Sanofi-aventis U.S. LLC | 4 | $136 |
| Johnson & Johnson | 8 | $101 |
| Amarin Pharma, Inc. | 1 | $74 |
| Novartis | 4 | $61 |
| Amgen | 4 | $60 |
| Merck | 4 | $59 |
| Boehringer Ingelheim | 3 | $40 |
| GSK | 2 | $28 |
| Biogen | 2 | $27 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $17 |
| Abbott | 1 | $15 |
| Bayer | 1 | $13 |
| Sanofi Pasteur Inc. | 1 | $13 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- UBRELVY$125
How this compares
$2,354 in reported general payments places this provider in the 85th percentile of 217 geriatric medicine providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 17 | $11,716 |
| RhopressaNetarsudil Mesylate | 12 | $3,591 |
| VyzultaLatanoprostene Bunod | 12 | $2,827 |
| Atorvastatin Calcium | 36 | $630 |
| Pantoprazole Sodium | 14 | $271 |
| Metoprolol Succinate | 14 | $247 |
| Allopurinol | 11 | $138 |
| ClopidogrelClopidogrel Bisulfate | 12 | $125 |
| Hydrochlorothiazide | 11 | $50 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $183 | $11,71617 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 217 geriatric medicine providers in Pennsylvania.
Other geriatric medicine in Johnstown
- J WieczorekJohnstown$884
- Richard StefanacciPhiladelphia$146K
- James LinErie$73K
- Adele TowersPittsburgh$29K
- Michele ZaworaPhiladelphia$21K
- Daniel HaimowitzLevittown$15K
- Robert PearlsteinPlymouth Meeting$15K
- Seth CarterErie$14K
- Moushumi KunduHanover$12K
- Jason KarlawishPhiladelphia$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.